Catalyst Pharmaceuticals (CPRX) Other Gross PP&E Adjustments (2016 - 2025)
Catalyst Pharmaceuticals (CPRX) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with -$10.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 11.28% year-over-year to -$10.8 million, compared with a TTM value of -$10.8 million through Dec 2025, up 11.28%, and an annual FY2025 reading of -$10.8 million, up 11.28% over the prior year.
- Other Gross PP&E Adjustments was -$10.8 million for Q4 2025 at Catalyst Pharmaceuticals, up from -$11.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$1.7 million in Q2 2023 and bottomed at -$29.1 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$6.9 million, with a median of -$2.9 million recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 23652.77% in 2021, then skyrocketed 53.55% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$2.0 million in 2021, then crashed by 35.98% to -$2.8 million in 2022, then crashed by 125.52% to -$6.2 million in 2023, then tumbled by 95.15% to -$12.2 million in 2024, then increased by 11.28% to -$10.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CPRX at -$10.8 million in Q4 2025, -$11.5 million in Q3 2025, and -$9.3 million in Q2 2025.